Correction: MALAT1 is Associated with Poor Response to Oxaliplatin-based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
Peilong Li, Xin Zhang, Haiyan Wang, Lili Wang, Tong Liu, Lutao Du, Yongmei Yang, Chuanxin Wang
Abstract
In the original version of this article (1), wrong images were used in Fig. 2F (invasion of si-NC–transfected HT29OxR cells), Fig. 4C (migration of HT29 cells), and Fig. 5G (si-EZH2–transfected SW620 cells). The error occurred when the authors arranged the images for these figures. The authors regret this error.
Topics & Concepts
OxaliplatinEZH2Colorectal cancerTransfectionRegretCancer researchMedicineOncologyCancerInternal medicineBiologyCell cultureEpigeneticsComputer scienceGeneticsGeneMachine learningCancer-related molecular mechanisms researchMicroRNA in disease regulationRNA modifications and cancer